Skip to main content
. 2017 Aug 2;2017(8):CD001324. doi: 10.1002/14651858.CD001324.pub5
Methods Women 'randomly allocated' into 3 groups. Method of randomisation not reported
Participants 360 women attending the family planning clinics in Chengwu (a county in Shandong), China. Women had regular menstrual periods and attended the clinic within 72 h of a single act of unprotected intercourse
Interventions Mife 25 mg orally, 2 doses, 12 h apart vs Mife 10 mg, for 5 days vs Mife 10 mg, for 3 days
Outcomes Observed number of pregnancies, side effects and changes in menstrual pattern
Notes
  1. Post‐randomisation exclusion and loss to follow‐up not reported

  2. Observed pregnancy/expected pregnancy/total number of women: Mife 25 mg twice 2/13/120; Mife 10 mg qd/5 days 0/12/118; Mife 10 mg qd/3 days 1/11/116

Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Mentioned randomisation but description not adequate
Allocation concealment (selection bias) Unclear risk Method of allocation concealment not mentioned
Blinding (performance bias and detection bias) All outcomes Unclear risk Not mentioned
Incomplete outcome data (attrition bias) All outcomes Unclear risk Post‐randomisation exclusion and loss to follow‐up not reported
Selective reporting (reporting bias) Low risk Reported planned outcomes
Other bias Low risk None detected